Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by Alphaseeker1984on Apr 13, 2018 12:03am
206 Views
Post# 27877523

A little cheese with the whine????

A little cheese with the whine????Sell your effing shares if you do not like the management you whiney bi&ches.,.every effing time the share price doesn't behave like some want or expect the same bozos are all bi&ching about management.   Crying because the share is not yet at $100 or $1000 or $1000000 per share....doesn't matter because the logic is the same.  Management is to blame for all the stock price misery....despite a very decent return in the last 18 months.  

Management is doing what they can to create shareholder value.   They have come a long way in 2 years and the trendline is higher.  However the stock is still not without risk and I do not blame some of the management for taking some money off the table.    If the drug sells well then the stock goes much higher, if not then who knows...maybe much lower.    Insider selling of options will have nothing to do with either outcome.   

 
Bullboard Posts